Insider filing · VKTX
Brian Lian
President & CEO
profile →
Viking Therapeutics, Inc.
VKTX · Healthcare · 22 filings in 24 months
ticker →
Brian Lian sold $4.9M of Viking Therapeutics (VKTX)
Executed Jul 29, disclosed Jul 30, the same day.
Value, as filed
$4.9M
148,517 sh × $33.32
Executed
Jul 29
the trade date, as filed
Disclosed
Jul 30
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BLBrian Lian (President & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $7.7M of VKTX (233,409 sh across 4 lots, as filed), executed Jan 5.
The name
VKTXHealthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Brian Lian in VKTX
VKTXSALE
Viking Therapeutics, Inc.
$7.7M233,409 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $1.4M
38,989 sh × $35.01
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $748K
26,889 sh × $27.80
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $8.3M
194,490 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $15.3M
215,930 sh across 2 lots
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET